Bellicum Pharmaceuticals, Inc. EPS - Earnings per Share 2015-2023 | BLCM
Bellicum Pharmaceuticals, Inc. eps - earnings per share from 2015 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Bellicum Pharmaceuticals, Inc. Annual EPS |
| 2022 |
$-0.81 |
| 2021 |
$-0.84 |
| 2020 |
$-1.34 |
| 2019 |
$-24.01 |
| 2018 |
$-24.37 |
| 2017 |
$-28.90 |
| 2016 |
$-25.70 |
| 2015 |
$-18.40 |
| 2014 |
$-340.40 |
| 2013 |
$-50.50 |
| 2012 |
$-42.60 |
| Bellicum Pharmaceuticals, Inc. Quarterly EPS |
| 2023-09-30 |
$-0.02 |
| 2023-06-30 |
$-0.24 |
| 2023-03-31 |
$-0.26 |
| 2022-12-31 |
$-0.20 |
| 2022-09-30 |
$-0.23 |
| 2022-06-30 |
$-0.13 |
| 2022-03-31 |
$-0.25 |
| 2021-12-31 |
$0.43 |
| 2021-09-30 |
$0.07 |
| 2021-06-30 |
$-0.22 |
| 2021-03-31 |
$-1.12 |
| 2020-12-31 |
$6.30 |
| 2020-09-30 |
$-0.18 |
| 2020-06-30 |
$-8.55 |
| 2020-03-31 |
$1.09 |
| 2019-12-31 |
$-5.83 |
| 2019-09-30 |
$-6.79 |
| 2019-06-30 |
$-5.85 |
| 2019-03-31 |
$-5.54 |
| 2018-12-31 |
$-6.07 |
| 2018-09-30 |
$-5.50 |
| 2018-06-30 |
$-6.00 |
| 2018-03-31 |
$-6.80 |
| 2017-12-31 |
$-6.60 |
| 2017-09-30 |
$-7.10 |
| 2017-06-30 |
$-7.40 |
| 2017-03-31 |
$-8.00 |
| 2016-12-31 |
$-7.40 |
| 2016-09-30 |
$-6.60 |
| 2016-06-30 |
$-6.10 |
| 2016-03-31 |
$-5.60 |
| 2015-12-31 |
$-6.30 |
| 2015-09-30 |
$-5.10 |
| 2015-06-30 |
$-4.00 |
| 2015-03-31 |
$-3.00 |
| 2014-12-31 |
$-286.30 |
| 2014-09-30 |
$-20.80 |
| 2014-06-30 |
$-18.10 |
| 2014-03-31 |
$-15.20 |
